ArticleEpilepsia2021

Post hoc analysis of a phase 3, multicenter, open-label study of cenobamate for treatment of uncontrolled focal seizures: Effects of dose adjustments of concomitant antiseizure medications.

William E Rosenfeld et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.